We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hepatic intra-arterial chemotherapy in patients with advanced primary liver tumours.
- Authors
Spada, Francesca; Fazio, Nicola; Bonomo, Guido; Monfardini, Lorenzo; Vigna, Paolo Della; Radice, Davide; Boselli, Sabrina; Orsi, Franco
- Abstract
Background: Primary liver tumours (PLTs) are currently a major health problem worldwide. The study's aim was to investigate the feasibility, toxicity, and activity of hepatic intra-arterial chemotherapy (HIAC) in patients with advanced PLTs. Methods: We retrospectively analysed 43 patients with advanced unresectable PLT, who were consecutively treated. HIAC with 5-fluorouracil, cisplatin, and mitomycin-C was administered through a radiologically positioned temporary percutaneous catheter every six weeks until tumour progression or unacceptable toxicity was reached. Results: Partial response was observed in 26% and stable disease in 41% of patients. The median overall survival was 12.3 months. Manageable catheter-related complications occurred in 23% of patients. The grade 3-4 toxicities included neutropenia, thrombocytopenia, and transaminitis. There were no toxic deaths. Conclusion: The results of this retrospective study show that HIAC is feasible, active, and manageable in patients with PLTs. The treatment could be studied in selected patients with advanced progressive HCC/BTC being treated with or ineligible for sorafenib/cisplatin plus gemcitabine.
- Subjects
LIVER tumors; TUMOR treatment; DRUG therapy; NEUTROPENIA; FLUOROURACIL; CISPLATIN; THROMBOCYTOPENIA
- Publication
Ecancermedicalscience, 2012, Vol 6, Issue 271-285, p1
- ISSN
1754-6605
- Publication type
Article
- DOI
10.3332/ecancer.2012.280